Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Allergies and your eyes: What you need to know this spring by Brandpoint

      Brandpoint

      News provided by

      Brandpoint

      Apr 19, 2016, 07:00 ET

      Share this article

      Share this article


      HOPKINS, Minn., April 19, 2016 /PRNewswire/ -- Spring is here and there are plenty of reasons to be excited about it. The warmer months mean it's time to say goodbye to shoveling, stiff breezes and dry skin, while saying hello to shorts, baseball and outdoor barbecues. That's good news. However, if you're an allergy sufferer, spring brings some unique challenges of its own and, depending on the severity of your allergies, they may be worse than that winter cold.

      Man plays fetch with dog in the park.
      Man plays fetch with dog in the park.

      There are many causes of springtime allergies and allergy sufferers everywhere are used to experiencing those familiar bouts of sneezing, stuffy nose and congestion.1 But not all allergy conditions are entirely nasal, and many allergy sufferers will show symptoms in their eyes as well.1 This is often caused by a condition called allergic conjunctivitis.2

      What is allergic conjunctivitis?

      Allergic conjunctivitis is an allergic reaction that occurs when the eyes - specifically the eyeball membrane known as the conjunctiva2 - are exposed to mold spores or pollen.1 Once exposed, the eyes may become itchy.3

      Research shows that 98 percent of people who experience eye allergies will be affected by seasonal allergic conjunctivitis.2  Spring is the most common time of the year for this condition, thanks to the propensity of grass, trees and flower pollens.2

      If you have allergic conjunctivitis and you suffer from itchy eyes in the spring time, you're not alone and you're not without options. Across the nation, eye allergy sufferers are alleviating their itchy eye symptoms with PAZEO® Solution (olopatadine hydrochloride ophthalmic solution) 0.7%.

      In clinical studies, once-daily PAZEO® Solution showed improved eye allergy itch relief at 24 hours (though not shortly after a drop was put in) compared to once-daily PATADAY® Solution (olopatadine hydrochloride ophthalmic solution) 0.2%, the #1 prescribed allergy eye drop. Once daily PAZEO® Solution showed improved eye allergy itch relief at 24 hours that was statistically significant compared to once daily PATADAY® Solution. 30 to 34 minutes after a drop was put in, the difference in itch relief was not statistically significant. The safety and effectiveness of PAZEO® Solution have been established in patients 2 years of age and older.4

      The most common side effects occurred in approximately 2% to 5% of patients. These side effects were blurred vision, dry eye, superficial punctate keratitis (a type of inflammation of the front part of the eye), impaired taste, and abnormal sensation in the eye.4

      INDICATION AND DOSING

      PAZEO® Solution is a prescription medicine used to treat eye itching associated with eye allergies. The recommended dosage is to put one drop in each affected eye once a day.

      IMPORTANT SAFETY INFORMATION

      Do not touch dropper tip to eyelids or surrounding areas. Touching may contaminate the dropper tip and PAZEO® Solution. Keep the bottle tightly closed when it is not in use.

      Do not wear contact lenses if your eyes are red. PAZEO® Solution should not be used to treat contact lens-related irritation. Always remove your contact lenses before administering PAZEO® Solution.

      PAZEO® Solution contains the preservative benzalkonium chloride (BAK). BAK may be absorbed by soft contact lenses. If you wear soft contacts, you should wait at least five minutes after administering PAZEO® Solution before inserting your contacts.

      You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.fda.gov/medwatch, or call 1-800-fda-1088.

      Please click here to view the full prescribing information for PAZEO® Solution. You can also ask your doctor if once-daily PAZEO® is right for you. To learn more, please contact Alcon customer service: 1-800-862-5266.

      1 American College of Allergy, Asthma & Immunology. Seasonal Allergies: Common Seasonal Allergy Triggers. Retrieved from http://acaai.org/allergies/types/seasonal. Accessed February 2016.

      2 Virtual Medical Centre. Simple Allergic Conjunctivitis (Seasonal Allergic Conjunctivitis (SAC); Perennial Allergic Conjunctivitis (PAC)). Retrieved from http://www.myvmc.com/diseases/simple-allergic-conjunctivitis-seasonal-allergic-conjunctivitis-sac-perennial-allergic-conjunctivitis-pac/#Statistics. Accessed February 2016.

      3 National Institutes of Health. Allergic Conjunctivitis. Retrieved from https://www.nlm.nih.gov/medlineplus/ency/article/001031.htm. Accessed February 2016.

      4 PAZEO Solution Package Insert.

      (c) 2016 Novartis    3/16   US-PAZ-16-E-0609

      Contact information: BrandpointContent.com

      Photo - http://photos.prnewswire.com/prnh/20160419/357333
      Logo - http://photos.prnewswire.com/prnh/20151218/297198LOGO

      SOURCE Brandpoint

      Modal title

      Also from this source

      Brandpoint launches Optimize360™ to help brands monitor and improve brand visibility in AI and generative search

      Brandpoint launches Optimize360™ to help brands monitor and improve brand visibility in AI and generative search

      Brandpoint today announced the launch of Optimize360™, an always-on brand visibility platform that helps PR and marketing communications leaders...

      For PR and MarCom professionals, brand discovery just changed: Brandpoint is first to market with AI visibility solution at scale

      For PR and MarCom professionals, brand discovery just changed: Brandpoint is first to market with AI visibility solution at scale

      Brandpoint today announced its evolution as the industry's first solution to create, distribute and measure brand campaigns across paid and earned...

      More Releases From This Source

      Explore

      Advertising

      Advertising

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Pharmaceuticals

      Pharmaceuticals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.